{
  "image_filename": "table_p5_det_4_005.png",
  "image_path": "Zimmerman_et_al.__2023_/extracted/figures/table_p5_det_4_005.png",
  "image_type": "Table",
  "page_number": 5,
  "block_id": "det_4_005",
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "supports_claim": false,
  "explanation": "A table showing vaccine effectiveness (VE) percentages with 95% confidence intervals for RIV4 and SD-IIV4 in adults aged 18\u201364 and \u226565 years, broken down by subgroups (overall, sex, risk condition, season). does not support the claim because the table only presents observed VE data for different vaccine types and subgroups and does not address mutations during production or their impact on effectiveness Note: Image quality is sufficient to read the VE estimates; no mention of production mutations is present.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table showing vaccine effectiveness (VE) percentages with 95% confidence intervals for RIV4 and SD-IIV4 in adults aged 18\u201364 and \u226565 years, broken down by subgroups (overall, sex, risk condition, season).",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table only presents observed VE data for different vaccine types and subgroups and does not address mutations during production or their impact on effectiveness",
    "confidence_notes": "Image quality is sufficient to read the VE estimates; no mention of production mutations is present."
  }
}